Clinical trial

Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)

NCT05798546

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-09-28

PhasePHASE1

Study timeline

Study start (actual)2022-09-28Date precision: day

Registry last updated2023-04-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Solid Tumorunresolved

Interventions

Neo-TBIOLOGICAL

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

FludarabineDRUG · verified · RxNorm: fludarabine

Interleukin-2DRUG

Sponsors & collaborators

BGI, Chinalead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technologycollaborator

Mapped research locations

WuhanHubei, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05798546 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.